Quantcast

Biovo Technologies Has Received CE Mark Approval for Its Airway Medix Closed Suction System

March 17, 2012

Biovo Technologies announced that it has received CE Mark approval for its Airway Medix Closed Suction System, a patented closed suction system designed to remove biofilm and secretion buildup from the inner lumen of the endotracheal tube. Bacterial buildup inside the endotracheal tube is considered one of the leading causes ventilator associated pneumonia (VAP) in intensive care units (ICU).

Tel Aviv, Israel (PRWEB) March 17, 2012

Biovo Technologies announced that it has received CE Mark approval for its Airway Medix Closed Suction System, a patented system designed to remove biofilm and secretion buildup from the inner lumen of the endotracheal tube. Bacterial buildup inside the endotracheal tube is considered one of the leading causes ventilator associated pneumonia (VAP) in intensive care units (ICU).

“This is a significant milestone in bringing our revolutionary VAP prevention solutions to intensive care units in Europe,” Biovo Technologies CTO Dr. Oron Zachar stated in a company press release. “We have seen an incredible level of interest in the new Airway Medix product line around the world, and we can now move determinedly forward with our development plans.”

VAP accounts for as much as 15% of all hospital-acquired infections (HAIs) and approximately 27% of all infections acquired in the intensive care unit ICU. The Airway Medix Closed Suction System is designed to remove secretions and minimize biofilm accumulation thus maintaining full patency of the endotracheal tube, supporting ventilation efficiency and minimizing the patient’s work of breathing.

The Airway Medix Closed Suction System is the first in a line of Airway Medix innovative, cost effective, disposable medical devices developed by Biovo Technologies that address VAP pathogenesis. Forthcoming products include a unique endotracheal tube employing a self-expanding cuff and a novel oral care kit.

About Biovo Technologies, Ltd.

Headquartered in Tel Aviv, Israel, Biovo Technologies is a pioneer in disposable medical devices for hospital intensive care units. The leading line of Airway Medix products are designed to improve patient safety and reduce VAP risk in the healthcare environment. Biovo Technologies engages, consults and employs leading technology and medical experts to ensure the highest quality products. The core technology team is committed to bringing best-of-breed products to the market that enhance the ability of physicians and healthcare professionals to perform their work on a daily basis with the added assurances that their patients are being provided the best care available. Visit http://www.biovo.net for more information.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/3/prweb9286865.htm


Source: prweb



comments powered by Disqus